|
Match
|
Document |
Document Title |
|
|
US20090291911 |
REHYDRATABLE POLYSACCHARIDE PARTICLES AND SPONGE
Tissue and other body structures may be protected using a hydrated composition made from free-flowing substantially collagen-free rehydratable polysaccharide particles and rehydratable...
|
|
|
US20090247486 |
COMPOSITION FOR ORAL SUBSTANCE COATING, COVERING MATERIAL FOR ORAL SUBSTANCE, EDIBLE CONTAINER AND ORAL SUBSTANCE USING THE SAME
A composition for oral substance coating, a covering material for an oral substance or an edible container, includes an indigestible and water-insoluble dietary fiber derived from a plant, alga or...
|
|
|
US20090246287 |
ANTI-ALLERGY COMPOSITIONS
The present invention relates to particles of glucans, particularly oxidized cellulosed for use in medicine. The invention further discloses pharmaceutical compositions for the treatment and/or...
|
|
|
US20090246167 |
STIMULI-RESPONSIVE SYSTEMS FOR CONTROLLED DRUG DELIVERY
A method of delivering a therapeutic agent by providing a cross-linked polymer encapsulating the therapeutic agent to a site in a patient. The degradation rate of the cross-linked polymer is...
|
|
|
US20090232892 |
Cellooligosaccharide-Containing Composition
Disclosed is a cellooligosaccharide composition comprising, as the main ingredient, at least one cellooligosaccharide selected from the group consisting of cellobiose, cellotriose, cellotetraose,...
|
|
|
US20090227537 |
SULFATED POLYSACCHARIDES AND USES THEREOF IN MEDICAL TREATMENT
The invention provides sulfated oxidised regenerated cellulose compounds, sulfated alginates, and the salts and hydrates thereof. The compounds are obtained by sulfation of oxidised regenerated...
|
|
|
US20090226503 |
ADHESION INHIBITING MATERIAL FOR VERTEBRAL/SPINAL OPERATION
It is to provide a material to inhibit spine/spinal cord adhesion in the form of a sponge, a film or a suspension to be used for the purpose of assisting/accelerating the tissue healing. An...
|
|
|
US20090176736 |
PHARMACEUTICAL COMPOSITION FOR CONFORMATIONAL DISEASES
A pharmaceutical composition is provided which is prophylactically and/or therapeutically effective for a conformational disease typified by Alzheimer's disease, prion disease, and amyloidosis. The...
|
|
|
US20090176735 |
PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY
A water-soluble cellulose derivative is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for regulating Stearoyl-CoA...
|
|
|
US20090175933 |
PREPARATION FOR THE TREATMENT OF DIARRHOEA
A preparation for the treatment of diarrhoea comprising a bulking agent and an anti-diarrhoeal agent wherein the anti-diarrhoeal agent is provided in the form of an anti-motility agent.
|
|
|
US20090149823 |
Application of Polymeric Materials to Screens To Facilitate Hemostasis And Wound Healing
This invention relates in general to a method and device for facilitating hemostasis and wound healing. In particular, the invention relates to the device comprising a polymeric material disposed...
|
|
|
US20090143331 |
POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY
Described herein are polysaccharide gel formulations including at least one inhibitor of polysaccharide degradation and methods of making the same. The methods described herein involve the steps of...
|
|
|
US20090093442 |
USES OF WATER-SOLUBLE CELLULOSE DERIVATIVES FOR PREVENTING OR TREATING METABOLIC SYNDROME
Water-soluble cellulose derivatives are useful in methods of preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome in an individual, and in...
|
|
|
US20090093441 |
PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY
A water-insoluble cellulose derivative, such as ethyl cellulose is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for...
|
|
|
US20090041743 |
SPERM-BLOCKING AGENT COMPOSITION WITH CONTRACEPTIVE EFFECT
A sperm-blocking agent is disclosed. The composition comprises an aqueous solvent a gum which is a polysaccharide having about 0.3 to 10 wt % of the composition, wherein the polysaccharide is...
|
|
|
US20090035350 |
Polymers for implantable devices exhibiting shape-memory effects
The present invention is directed to polymeric compositions comprising a biodegradable copolymer that possesses shape-memory properties and implantable devices (e.g., drug-delivery stents) formed...
|
|
|
US20090035339 |
Methods of Inactivating Viruses
A method of inactivating viruses is provided. The method comprises the step of topically applying an antimicrobial composition comprising: an organic acid; and an anionic surfactant mixture having...
|
|
|
US20090004253 |
Composite device for the repair or regeneration of tissue
The present invention is directed to composite devices comprising a tissue-engineering scaffold and an anionic polysaccharide/structural protein coating. The composite devices are useful for the...
|
|
|
US20080305138 |
Photostable Wound Dressing Materials and Methods of Production Thereof
The invention provides a method of preparing an antimicrobial sponge material for medicinal use, comprising the steps of: treating an anionic polysaccharide with a solution of a silver salt to...
|
|
|
US20080269163 |
Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis
Described herein are methods for protecting cells from ultrasound-mediated cytolysis.
|
|
|
US20080268048 |
PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND FOR REDUCING THE RISK OF CONGENITAL ABNORMALITIES
The pharmaceutical composition for oral contraception and for reducing the risk of congenital abnormalities contains, in a daily dosage unit, 2.0 mg or 1.5 mg of...
|
|
|
US20080254015 |
Gel Composition of Citrus Complex Carbohydrates Cross-Linked with Cellulose Derivate
A gel for application to a wound, comprising a mixture of citrus complex carbohydrates, a cellulose derivative, a polyol component and water, wherein said citrus complex carbohydrates are...
|
|
|
US20080227753 |
Nano-sized Bagasse Fiber
A new composition of nanosized bagasse fibers has been made by a method which reduces the sugarcane bagasse fibers to nano-sized particles while retaining the natural components of the bagasse. The...
|
|
|
US20080220068 |
TREATMENT AND PREVENTION OF EXCESSIVE SCARRING
A pharmaceutical composition comprised of a hydration agent and an anesthetic can be used to treat excessive scarring conditions, such as keloid and hypertrophic scars.
|
|
|
US20080193558 |
Stabilized and preserved ketotifen ophth almic compositions
Ophthalmic compositions comprising ketotifen, a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v), one or more ocular-compatible hydrogen...
|
|
|
US20080176819 |
METHOD OF PREVENTING OR TREATING METABOLIC SYNDROME
Water-insoluble cellulose derivatives such as ethyl cellulose can be used to treat or prevent metabolic syndrome and/or one of the abnormalities of metabolic syndrome.
|
|
|
US20080161266 |
Ophthalmic Alginate Composition Related Methods of Manufacture and Methods of Use
The present invention is directed to an ophthalmic composition comprising alginate having a minimum of about 0% and a maximum of about 50% guluronic units bound to an adjacent guluronic unit as a...
|
|
|
US20080152698 |
HYDROGEL
A hydrogel comprises at least 50% by weight of water, at least one gel-forming polysaccharide, at least one acrylic acid derivative and one electrolyte mixture, the electrolyte mixture containing...
|
|
|
US20080132468 |
Monitoring of Wounds by Measurement of Protease and Protease Inhibitor Levels in Wound Fluids
A diagnostic test apparatus for determining a ratio of: (a) at least one endogenous protease enzyme inhibitor, to (b) at least one endogenous protease enzyme, in a sample of a wound fluid. Suitably...
|
|
|
US20080113936 |
PROCESS FOR THE PREPARATION OF ADSORBATES OF VALSARTAN AND/OR ITS SOLVATES OR HYDRATES
The present invention relates to a process for the preparation of adsorbates of valsartan and/or its solvates or hydrates wherein one starts with a solution of valsartan or of one of its...
|
|
|
US20080113935 |
Use of lipid conjugates in the treatment of diseases or disorders of the eye
In one embodiment, the invention provides a method of treating, reducing the incidence, reducing the severity or pathogenesis of an eye disease or disorder in a subject, including, inter alia,...
|
|
|
US20080102117 |
BASE MATERIAL FOR DRY DIRECT TABLETING COMPRISING LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
It is an object of the present invention to modify low-substituted hydroxypropyl cellulose added as a binder and disintegrator in the formation of tablets, so as to serve as a base material for dry...
|
|
|
US20080089918 |
Viscoelastic Solutions Containing Sodium Hyaluronate And Hydroxypropyl Methyl Cellulose, Preparation And Uses
The present invention relates to: biocompatible, viscoelastic aqueous solutions based on a mixture of sodium hyaluronate(s) (NaHA) and hydroxypropyl methyl cellulose(s) (HPMC), which contain:
...
|
|
|
US20080069857 |
Compositions And Methods For Inhibiting Adhesions
The present invention provides compositions and methods for inhibiting adhesions. The methods involve administering solutions containing hydrogel precursors such as polysaccharide derivatives,...
|
|
|
US20080044456 |
Cellulose membrane drying process
A method of membrane drying of bacterial cellulose, characterized by the fact that the membrane is stuck to a device and under tension, for acquirement of a dry pellicle with plain, flat and...
|
|
|
US20080039398 |
Formulations and methods for treating dry eye
The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are...
|
|
|
US20080038219 |
Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
A novel topical preparation comprised of carboxylic acids, chelating agents, dimethyl Sulfone and magnesium sulfate that forms a functional and versatile base formation for the addition of numerous...
|
|
|
US20080027026 |
Composition for the treatment of inflammatory conditions
A novel treatment for topical inflammatory conditions such as acne, eczema, shingles, insect bites and hives is provided, consisting of the application of a pharmaceutical cream or ointment which...
|
|
|
US20080020017 |
Intraocular Irrigating Solution Having Improved Flow Characteristics
Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by...
|
|
|
US20080008738 |
Flexible bioresorbable hemostatic packing and stent
The invention provides a flexible bioresorbable foam having hemostatic properties. The foam is formed from a carboxymethylcellulose suspension.
|